Cardiac transthyretin amyloidosis

1 paper1 finding

Associations

Frailty

upin humans1

1 study

Cardiac transthyretin amyloidosis is associated with frailty in humans (66% (95% CI 57-74%)).
“A meta-analysis restricted to studies using the Clinical Frailty Scale (N = 1164) yielded a pooled frailty prevalence of 66 % (95 % CI, 57-74 %)”
Reviewin cardiac transthyretin amyloidosisn = 1,164
Prevalence of frailty in cardiac transthyretin amyloidosis: A systematic review and meta-analysis
Ageing research reviews5 Oct 2025

Ageing Research Reviews8 Oct

Meta-analysis of observational studiesCardiac amyloidosis